TCM Biotech International (ROCO:4169) Additional Paid-In Capital : NT$415.8 Mil(As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Additional Paid-In Capital?

TCM Biotech International's quarterly additional paid-in capital stayed the same from Dec. 2022 (NT$13.8 Mil) to Jun. 2023 (NT$13.8 Mil) but then increased from Jun. 2023 (NT$13.8 Mil) to Dec. 2023 (NT$415.8 Mil).

TCM Biotech International's annual additional paid-in capital stayed the same from Dec. 2021 (NT$13.8 Mil) to Dec. 2022 (NT$13.8 Mil) but then increased from Dec. 2022 (NT$13.8 Mil) to Dec. 2023 (NT$415.8 Mil).

TCM Biotech International Additional Paid-In Capital Historical Data

The historical data trend for TCM Biotech International's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Additional Paid-In Capital Chart

TCM Biotech International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

12.09

13.82

415.77

TCM Biotech International Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															13.82	13.82	13.82	13.82	415.77

TCM Biotech International Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

TCM Biotech International Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

TCM Biotech International (ROCO:4169) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221

Website

http://www.tcmbio.com

TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International (ROCO:4169) Headlines

No Headlines